Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Evotec AG    EVT   DE0005664809

EVOTEC AG (EVT)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsOfficial PublicationsSector newsTweets
OFFRE
Most relevant news about EVOTEC AG
09/19EVOTEC : and Almirall enter into research collaboration in the field of dermatol..
AQ
09/17EVOTEC : And almirall enter into research collaboration in the field of dermatol..
EQ
09/13EVOTEC : And Celgene Enter Partnership In The Field Of Targeted Protein Degradat..
AQ
09/11EVOTEC : and Celgene enter partnership in the field of targeted protein degradat..
AQ
09/11EVOTEC AG : listed in MDAX
AQ
09/11EVOTEC AG : Release according to Article 40, Section 1 of the WpHG [the German S..
EQ
09/06EVOTEC AG : Release according to Article 40, Section 1 of the WpHG [the German S..
EQ
09/06EVOTEC : Listed in mdax
EQ
09/06EVOTEC : And celgene enter partnership in the field of targeted protein degradat..
EQ
09/05EVOTEC : to attend upcoming investor conferences
AQ
09/03EVOTEC AG : Release according to Article 40, Section 1 of the WpHG [the German S..
EQ
09/03EVOTEC : To attend upcoming investor conferences
AQ
09/03EVOTEC : To attend upcoming investor conferences
EQ
08/31EVOTEC AG : Release according to Article 41 of the WpHG [the German Securities T..
EQ
08/30EVOTEC : And chdi foundation extend ongoing collaboration to fight huntington's ..
EQ
More most relevant news
All news about EVOTEC AG
09/19EVOTEC : and Almirall enter into research collaboration in the field of dermatol..
AQ
09/17EVOTEC AG : Evotec And Almirall Enter Into Research Collaboration In The Field O..
AC
09/17EVOTEC : And almirall enter into research collaboration in the field of dermatol..
EQ
09/13EVOTEC : And Celgene Enter Partnership In The Field Of Targeted Protein Degradat..
AQ
09/11EVOTEC : and Celgene enter partnership in the field of targeted protein degradat..
AQ
09/11EVOTEC AG : listed in MDAX
AQ
09/11EVOTEC AG : Release according to Article 40, Section 1 of the WpHG [the German S..
EQ
09/08EVOTEC : Evotech And Celgene Enter Partnership In The Field Of Targeted Protein ..
AQ
09/06EVOTEC : CENTOGENE and Evotec Sign Global Strategic Partnership on Drug Discover..
AQ
09/06EVOTEC AG : Release according to Article 40, Section 1 of the WpHG [the German S..
EQ
More news
Sector news : Biotechnology & Medical Research - NEC
09/19NOVARTIS : U.K. Pulls Brakes on Novartis' CAR-T Drug in First European Setback -..
DJ
09/19NOVARTIS : U.K. Pulls Brakes on Novartis' CAR-T Drug for Some Patients Despite D..
DJ
09/19GILEAD SCIENCES : UK rejects adult Novartis CAR-T therapy, after 'yes' in kids
RE
09/18REGENERON PHARMACEUTICALS : Sanofi pledges to keep up its restructuring efforts
RE
09/14Allogene, Which Announced Pfizer Agreement in April, Discloses IPO Plans
DJ
09/14Allogene, Which Announced Pfizer Agreement in April, Discloses IPO Plans -- U..
DJ
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
08/27CENTOGENE and Evotec sign global strategic partnership on drug discovery proj.. 
08/12Evotec AG 2018 Q2 - Results - Earnings Call Slides 
08/12Evotec AG (EVOTF) CEO Werner Lanthaler on Q2 2018 Results - Earnings Call Tra.. 
08/09Evotec AG reports Q2 results 
05/31Evotec forms LAB591 with Arix Bioscience and Fred Hutchinson Cancer Research .. 
05/21Celgene teams up with Evotec to discover new cancer treatments 
Latest Tweets
09/21Celgene $CELG vs. Evotec $EVTCY Head to Head Review  
09/19lunchtime: a lot of action everywhere! Pharnext $ALPHA -5% argenx $ARGX -9% $.. 
09/17? DGAP-News: EVOTEC AND ALMIRALL ENTER INTO RESEARCH COLLABORATION IN THE FIE..
1
09/17EVOTEC AND ALMIRALL ENTER INTO RESEARCH COLLABORATION IN THE FIELD OF DERMATO..
3
09/11Evotec AG: Release according to Article 40, Section 1 of the WpHG [the German.. 
More tweets
Qtime:41
Financials (€)
Sales 2018 350 M
EBIT 2018 44,5 M
Net income 2018 33,9 M
Debt 2018 80,0 M
Yield 2018 -
P/E ratio 2018 77,98
P/E ratio 2019 58,94
EV / Sales 2018 8,11x
EV / Sales 2019 7,11x
Capitalization 2 762 M
Chart EVOTEC AG
Duration : Period :
Evotec AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EVOTEC AG
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 6
Average target price 23,2 €
Spread / Average Target 24%
EPS Revisions
Managers
NameTitle
Werner Lanthaler Chief Executive Officer
Wolfgang Plischke Chairman-Supervisory Board
Mario Eugenio Cosimino Polywka Chief Operating Officer
Enno Spillner Chief Financial Officer
Cord E. Dohrmann Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
EVOTEC AG38.63%3 245
CELLTRION, INC.--.--%33 388
IQVIA HOLDINGS INC30.32%25 763
LONZA GROUP18.80%24 291
INCYTE CORPORATION-29.69%14 156
SEATTLE GENETICS, INC.45.35%12 348